Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 984 GBX -1.78% Market Closed
Market Cap: 1.3B GBX
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

GNS Price Targets Summary
Genus PLC

Wall Street analysts forecast GNS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNS is 2 482 GBX with a low forecast of 1 868.5 GBX and a high forecast of 3 255 GBX.

GNS Lowest Forecast
Wall Street Target
1 868.5 GBX
6% Downside
GNS Average Forecast
Wall Street Target
2 482 GBX
25% Upside
GNS Highest Forecast
Wall Street Target
3 255 GBX
64% Upside
Lowest
Price Target
1 868.5 GBX
6% Downside
Average
Price Target
2 482 GBX
25% Upside
Highest
Price Target
3 255 GBX
64% Upside
Genus PLC Competitors:
Price Targets
NGNE
Neurogene Inc
116% Upside
MSB
Mesoblast Ltd
59% Upside
TSHA
Taysha Gene Therapies Inc
190% Upside
STOK
Stoke Therapeutics Inc
98% Upside
NGNE
Neurogene Inc
116% Upside
MSB
Mesoblast Ltd
59% Upside
TSHA
Taysha Gene Therapies Inc
190% Upside
STOK
Stoke Therapeutics Inc
98% Upside
TGTX
TG Therapeutics Inc
22% Upside
DVAX
Dynavax Technologies Corp
138% Upside
TNGX
Tango Therapeutics Inc
118% Upside
ZNTL
Zentalis Pharmaceuticals Inc
346% Upside

Revenue
Forecast

Revenue Estimate
Genus PLC

For the last 8 years the compound annual growth rate for Genus PLC's revenue is 7%. The projected CAGR for the next 4 years is 4%.

7%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Genus PLC

For the last 8 years the compound annual growth rate for Genus PLC's operating income is 4%. The projected CAGR for the next 4 years is 17%.

4%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Genus PLC

For the last 8 years the compound annual growth rate for Genus PLC's net income is -20%. The projected CAGR for the next 4 years is 81%.

-20%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
GNS intrinsic value, competitors valuation, and company profile.
DCF Valuation
GNS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GNS stock valuation using valuation multiples.
Wall Street Estimates
GNS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GNS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GNS's stock price target?
Price Target
2 482 GBX

According to Wall Street analysts, the average 1-year price target for GNS is 2 482 GBX with a low forecast of 1 868.5 GBX and a high forecast of 3 255 GBX.

What is Genus PLC's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Genus PLC's revenue is 7%. The projected CAGR for the next 4 years is 4%.

What is Genus PLC's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Genus PLC's operating income is 4%. The projected CAGR for the next 4 years is 17%.

What is Genus PLC's Net Income forecast?
Projected CAGR
81%

For the last 8 years the compound annual growth rate for Genus PLC's net income is -20%. The projected CAGR for the next 4 years is 81%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.